Uterine Artery Embolization
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".
Deadline for manuscript submissions: closed (30 December 2021) | Viewed by 2426
Special Issue Editors
Interests: obstetrics and gynecology
Special Issues, Collections and Topics in MDPI journals
Interests: obstetrics and gynecology
Special Issue Information
Dear Colleagues,
Uterine fibroids are high prevalent benign tumors of women of reproductive age, causing very often symptoms (heavy menstrual bleeding, abdominal pain, anemia, pressure symptoms) that affect negatively their quality of life Uterine Artery Embolization (UAE), first described by Ravina et al in 1995, is gaining acceptance as a minimal invasive treatment alternative to surgery and her safety and efficacy mainly comparing with surgery was confirmed in several randomized controlled trials Embolization is currently the most used non-surgical invasive technique. The majority of women report satisfactory post-treatment results like shorter hospitalization period and recovery time in comparison to hysterectomy and improvement or complete remission of clinical symptoms The treatment of fibroids should be individualized based on their size, location, growth rate, the symptoms that they cause, the desire to have children and the age of the woman.. According to results from our Department were founded no negative impact of UAE on ovarian reserve of normal menstruating premenopausal women and no important changes inflammatory parameters after the procedure. This procedure is also of great importance in the reproductive period because a discussion about the effect of fibroids on reproductive outcome is still open . In the future embolization could be generally recommended as treatment option for women who desire future fertility/pregnancy.
Prof. Panagiotis Tsikouras
Prof. Dr. Georgios Galazios
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nonsurgical uterine fibroids treatment
- uterine artery embolization
